BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
$16.81
As on 02-Sep-2026 14:43EDT
Market cap
$1,061 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
6.8
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-- Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$58
-
EPS
$1.8
-
Face value
--
-
Shares outstanding
62,501,404
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| 11.7 | 8.6 | 15.5 | 17.1 | 2.4 | -10.4 | -- |
|
BSE Sensex
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| 4.5 | -1.7 | -5.1 | -39.2 | -6.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
16.8 | 1,060.7 | 24.1 | 23.5 | -- | 3.5 | 6.8 | 1.0 |
| 15.9 | 1,649.2 | 225.0 | 222.0 | -- | 13.4 | 7.5 | 1.0 | |
| 22.6 | 1,432.2 | 82.5 | 54.5 | 170.8 | 3.5 | 16.3 | 0.9 | |
| 30.7 | 2,089.1 | 266.0 | 314.4 | -- | 20.3 | 6.6 | 1.2 | |
| 12.4 | 3,291.2 | 948.0 | -375.0 | 6.8 | -6.7 | -- | 0.7 | |
| 66.6 | 1,599.1 | 24.4 | 376.7 | 10.6 | 20.5 | 4.2 | 0.9 | |
| 15.0 | 2,474.3 | 185.4 | 490.6 | -13.8 | 19.7 | 5.1 | 0.9 | |
| 12.5 | 1,786.8 | 30.7 | 30.6 | -- | 2.1 | 7 | 1.0 | |
| 18.5 | 1,757.2 | 101.9 | 174.1 | -- | 8 | 11.9 | 0.8 | |
| 35.6 | 1,891.9 | 204.6 | 254.3 | -- | 13.1 | 7.2 | 1.0 |
Shareholding Pattern
View DetailsAbout BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
--
-
Portfolio Mang.
Mr. Jeffrey Gene Lee
-
Portfolio Manager
Dr. Xiang Liu Ph.D.
-
Headquarters
New York, NY
-
Website
--
FAQs for BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
What is the current share price of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) Today?
The share price of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is $16.81 (NYSE) as of 02-Sep-2026 14:43 EDT. BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has given a return of 2.39% in the last 3 years.
What is the current PB & PE ratio of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)?
The P/E ratio of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is 6.79 times as on 21-Aug-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
8.14 |
0.25 |
2023 |
10.21 |
0.35 |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
What is the 52 Week High and Low of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)?
The 52-week high and low of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) are Rs 17.25 and Rs 13.70 as of 03-Sep-2026.
What is the market cap of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)?
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has a market capitalisation of $ 1,061 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)?
Before investing in BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.